Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trokendi XR in Pediatric Epilepsy
NCT01284530Phase 2Completed
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Start
- Jan 2011
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topiramate in epilepsy, sponsored by Supernus Pharmaceuticals, Inc.. Started Jan 2011; status: completed.
02
Drugs
topiramate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT01284530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01284530.